{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:22:38Z","timestamp":1787710958859,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06137-5","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T09:13:12Z","timestamp":1781687592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined AGT M235T-ACE I\/D genotype and risk of essential hypertension in Vietnamese adults: a hospital-based case-control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Thanh Tuan","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc Hoa","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc Khanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"10304","key":"6137_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(21)01330-1.","journal-title":"Lancet"},{"key":"6137_CR2","doi-asserted-by":"publisher","first-page":"1045202","DOI":"10.3389\/fpubh.2022.1045202","volume":"10","author":"LTH Vu","year":"2022","unstructured":"Vu LTH, Bui QTT, Khuong LQ, Tran BQ, Pham HTT, Nguyen LH, et al. Trend of metabolic risk factors among the population aged 25\u201364 years for non-communicable diseases over time in Vietnam: A time series analysis using national STEPs survey data. Front Public Health. 2022;10:1045202. https:\/\/doi.org\/10.3389\/fpubh.2022.1045202.","journal-title":"Front Public Health"},{"issue":"Suppl D","key":"6137_CR3","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/eurheartj\/suz076","volume":"21","author":"NL Van Huynh","year":"2019","unstructured":"Van Huynh NL, Viet CT, Sinh H, Manh NTT, Hien, Chow CK, et al. Blood pressure screening during the May Measurement Month 2017 programme in Vietnam-South-East Asia and Australasia. Eur Heart J Suppl. 2019;21(Suppl D):D127\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/suz076.","journal-title":"Eur Heart J Suppl"},{"key":"6137_CR4","doi-asserted-by":"publisher","unstructured":"Van Huynh NL, Viet CT, Sinh CK, Kruger A et al. May Measurement Month 2018: an analysis of blood pressure screening results from Vietnam. Eur Heart J Suppl. 2020;22(Suppl H):H139-H141. https:\/\/doi.org\/10.1093\/eurheartj\/suaa063","DOI":"10.1093\/eurheartj\/suaa063"},{"key":"6137_CR5","doi-asserted-by":"publisher","unstructured":"Van Huynh NR, Nguyen Lan Viet, Nguyen Thi Thu Hien, Tran Thi My Hanh, Beaney T et al. Blood pressure screening results from May Measurement Month 2019 in Vietnam. Eur Heart J Suppl. 2021;23(Suppl B):B154-B157. https:\/\/doi.org\/10.1093\/eurheartj\/suab051","DOI":"10.1093\/eurheartj\/suab051"},{"key":"6137_CR6","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","volume":"4","author":"S Oparil","year":"2018","unstructured":"Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cifkova R, Dominiczak AF, et al. Hypertens Nat Rev Dis Primers. 2018;4:18014. https:\/\/doi.org\/10.1038\/nrdp.2018.14.","journal-title":"Hypertens Nat Rev Dis Primers"},{"issue":"3","key":"6137_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/ijms19030688","volume":"19","author":"A Russo","year":"2018","unstructured":"Russo A, Di Gaetano C, Cugliari G, Matullo G, Ehret GB. Advances in the genetics of hypertension: the effect of rare variants. Int J Mol Sci. 2018;19(3):688. https:\/\/doi.org\/10.3390\/ijms19030688.","journal-title":"Int J Mol Sci"},{"issue":"29","key":"6137_CR8","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/eurheartj\/ehx159","volume":"38","author":"TJ Niiranen","year":"2017","unstructured":"Niiranen TJ, McCabe EL, Larson MG, Henglin M, Lakdawala NK, Vasan RS, et al. Risk for hypertension crosses generations in the community: a multi-generational cohort study. Eur Heart J. 2017;38(29):2300\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehx159.","journal-title":"Eur Heart J"},{"issue":"8 Suppl B","key":"6137_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18553\/jmcp.2007.13.s8-b.9","volume":"13","author":"SA Atlas","year":"2007","unstructured":"Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8 Suppl B):9\u201320. https:\/\/doi.org\/10.18553\/jmcp.2007.13.s8-b.9.","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"6137_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/01.HYP.0000227932.13687.60","volume":"48","author":"ME Dickson","year":"2006","unstructured":"Dickson ME, Sigmund CD. Genetic basis of hypertension: revisiting angiotensinogen. Hypertension. 2006;48(1):14\u201320. https:\/\/doi.org\/10.1161\/01.HYP.0000227932.13687.60.","journal-title":"Hypertension"},{"issue":"1","key":"6137_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0092-8674(92)90275-H","volume":"71","author":"X Jeunemaitre","year":"1992","unstructured":"Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71(1):169\u201380. https:\/\/doi.org\/10.1016\/0092-8674(92)90275-H.","journal-title":"Cell"},{"issue":"12 Pt 2","key":"6137_CR12","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1097\/00004872-199816121-00014","volume":"16","author":"AH Danser","year":"1998","unstructured":"Danser AH, Derkx FH, Hense HW, Jeunemaitre X, Riegger GA, Schunkert H. Angiotensinogen (M235T) and angiotensin-converting enzyme (I\/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens. 1998;16(12 Pt 2):1879\u201383. https:\/\/doi.org\/10.1097\/00004872-199816121-00014.","journal-title":"J Hypertens"},{"issue":"2","key":"6137_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/ajcn\/88.2.392","volume":"88","author":"T Norat","year":"2008","unstructured":"Norat T, Bowman R, Luben R, Welch A, Khaw KT, Wareham N, et al. Blood pressure and interactions between the angiotensinogen polymorphism AGT M235T and sodium intake: a cross-sectional population study. Am J Clin Nutr. 2008;88(2):392\u20137. https:\/\/doi.org\/10.1093\/ajcn\/88.2.392.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"6137_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/HJH.0b013e328333d930","volume":"28","author":"LD Ji","year":"2010","unstructured":"Ji LD, Zhang LN, Shen P, Wang P, Zhang YM, Xing WH, et al. Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I\/D polymorphisms with essential hypertension in Han Chinese population: a meta-analysis. J Hypertens. 2010;28(3):419\u201328. https:\/\/doi.org\/10.1097\/HJH.0b013e328333d930.","journal-title":"J Hypertens"},{"key":"6137_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2261-5-7","volume":"5","author":"YH Say","year":"2005","unstructured":"Say YH, Ling KH, Duraisamy G, Isaac S, Rosli R. Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: a case-control study. BMC Cardiovasc Disord. 2005;5:7. https:\/\/doi.org\/10.1186\/1471-2261-5-7.","journal-title":"BMC Cardiovasc Disord"},{"key":"6137_CR16","doi-asserted-by":"publisher","first-page":"538053","DOI":"10.1155\/2014\/538053","volume":"2014","author":"KD Singh","year":"2014","unstructured":"Singh KD, Jajodia A, Kaur H, Kukreti R, Karthikeyan M. Gender specific association of RAS gene polymorphism with essential hypertension: a case-control study. Biomed Res Int. 2014;2014:538053. https:\/\/doi.org\/10.1155\/2014\/538053.","journal-title":"Biomed Res Int"},{"key":"6137_CR17","doi-asserted-by":"publisher","unstructured":"Tran TT, Chau NH, Nguyen DK. Dataset for combined AGT M235T-ACE I\/D genotype and risk of essential hypertension in Vietnamese adults. Zenodo. 2026. https:\/\/doi.org\/10.5281\/zenodo.19326602","DOI":"10.5281\/zenodo.19326602"},{"key":"6137_CR18","unstructured":"Tran TT, Relationship between AGT, M235T, ACE I\/D. and AGTR1 A1166C variants and essential hypertension. PhD dissertation. University of Medicine and Pharmacy at Ho Chi Minh City; 2024. Available from: https:\/\/ump.edu.vn\/tuyen-sinh-dao-tao\/sau-dai-hoc\/tien-si\/thong-bao\/7930\/thong-tin-luan-an-dua-len-mang-cua-ncs-tran-thanh-tuan"},{"issue":"9","key":"6137_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/jch.14580","volume":"24","author":"T Van Huynh","year":"2022","unstructured":"Van Huynh T, Van Huy. Doan Pham Phuoc Long, Hoang Anh Tien. Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension. J Clin Hypertens (Greenwich). 2022;24(9):1121\u201338. https:\/\/doi.org\/10.1111\/jch.14580.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"6137_CR20","doi-asserted-by":"publisher","first-page":"e1000022","DOI":"10.1371\/journal.pmed.1000022","volume":"6","author":"J Little","year":"2009","unstructured":"Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, von Elm E, et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009;6(2):e1000022. https:\/\/doi.org\/10.1371\/journal.pmed.1000022.","journal-title":"PLoS Med"},{"issue":"9403","key":"6137_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(03)15268-3.","journal-title":"Lancet"},{"key":"6137_CR22","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes. In: Standards of Medical Care in Diabetes-2016. Diabetes Care. 2016;39(Suppl 1):S13-S22. https:\/\/doi.org\/10.2337\/dc16-S005","DOI":"10.2337\/dc16-S005"},{"key":"6137_CR23","volume-title":"WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS): STEPS Instrument, version 3.2","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS): STEPS Instrument, version 3.2. Geneva: World Health Organization; 2024."},{"key":"6137_CR24","volume-title":"The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care","author":"TF Babor","year":"2001","unstructured":"Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. 2nd ed. Geneva: World Health Organization; 2001.","edition":"2"},{"key":"6137_CR25","volume-title":"Understanding Alcohol Drinking Patterns","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2025","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Understanding Alcohol Drinking Patterns. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2025."},{"issue":"24","key":"6137_CR26","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","volume":"54","author":"FC Bull","year":"2020","unstructured":"Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451\u201362. https:\/\/doi.org\/10.1136\/bjsports-2020-102955.","journal-title":"Br J Sports Med"},{"issue":"3","key":"6137_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","volume":"52","author":"M de Gasparo","year":"2000","unstructured":"de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52(3):415\u201372.","journal-title":"Pharmacol Rev"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06137-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06137-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06137-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:08:33Z","timestamp":1787710113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06137-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6137"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06137-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee in Biomedical Research of the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam, under Decision No. 439\/\u0110HYD-H\u0110\u0110\u0110 dated 12 December 2018. Written informed consent was obtained from all participants before enrollment. Participant recruitment and sample collection took place from 1 January 2019 to 1 May 2019. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"744"}}